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Diffusive and convective transfer of cytokine-inducing bacterial prod-
ucts across hemodialysis membranes. The widespread use of bicarbonate
dialysate, and high-flux and high-efficiency dialyzers have raised concerns
regarding the transmembrane passage of bacterial products from the
dialysate into the blood compartment. To study the mechanisms as well as
magnitude of the transmembrane transfer of bacterial products from the
dialysate, we developed a computerized in vitro dialysis model which
provides continuous pressure recording from the arterial, venous, dialy-
sate inflow and outflow ports. By virtue of a computer controlled on-line
infusion pump, this model permits control of ultrafiltration/backfiltration.
Heparinized (10 U/mI) whole blood (150 ml) was circulated through the
blood compartment for 120 minutes at 100 mI/mm. Bicarbonate dialysate
contaminated with Pseudomonas malt ophilia filtrate was circulated
through the dialysate compartment at 100 ml/min. A two-point pressure of
+10 mm of Hg (ultrafiltration) was maintained for the first 60 minutes and
—10 mm of Hg (backfiltration) for the next 60 minutes. Whole blood
samples (10 ml) were drawn from the blood at 0, 60 and 120 minutes.
Peripheral blood mononuclear cells (PBMC) harvested from these sam-
ples were incubated for 24 hours in tissue culture medium. In addition, 0.5
ml samples of dialysate were collected at 0, 60 and 120 minutes and
incubated with PBMC from the same donor for 24 hours. After 24 hour
incubation, total cell-associated IL-iRa and IL-1f3 were measured by
specific radioimmunoassay. Paired experiments were performed with eight
high-flux synthetic membranes (polyamide) and eight low-flux cellulose
membranes (hemophan). Cytokine production is expressed as pgJ2.5
million PBMC. During the mandatory ultrafiltration phase of the experi-
ment (first hour), the production of IL-iRa by PBMC from the blood
compartment rose from 515 118 to 785 209 with polyamide
membranes, and from 1175 365 to 3865 1847 with hemophan
membranes, suggesting diffusive transport of bacterial products across the
membrane. In contrast, at the end of the backfiltration phase (second
hour), there was no further rise in the production of IL-iRa by PBMC
from the blood compartment (702 123 with polyamide, and 2284 886
with hemophan). The production of IL-iRa by PBMC harvested from the
blood compartment of polyamide membranes at 0, 60 and 120 minutes was
lower than that with hemophan membranes (P = 0.01). In contrast to
IL-iRa, the production of IL-113 by PBMC harvested from the blood
compartment with both membranes was uniformly low. The results of this
study demonstrate the diffusive transfer of bacterial products across
dialysis membranes. Therefore, any condition that increases diffusive
transport such as dialyzers with large surface areas and high blood and
dialysate flow rates could potentially increase the reverse transfer of
bacterial products from the dialysate. This risk is not greater for synthetic
high-flux membranes such as polyamide. Further, IL-1f3 is a less sensitive
indicator than IL-iRa of the transmembrane passage of cytokine-inducing
substances from the dialysate to blood compartment.
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The widespread use of bicarbonate dialysate, which is a good
bacterial culture medium [1], and the increasing popularity of
high-efficiency and high-flux dialyzers [21 have kindled interest in
the potential transfer of bacterial products from the dialysate into
the blood compartment [3]. The large surface areas of the
dialyzers, and the potential for backflltration have also raised
questions concerning the relative roles of diffusive and convective
transport of bacterial products from the dialysate to blood com-
partment. Consequently, the need for sterile dialysate, beyond the
requirements of the Association for Advancement of Medical
Instrumentation (AAMI) [4] has been a subject of considerable
debate [5—81.
The limulus amebocyte lysate assay is an insensitive indicator of
the transmembrane transfer of bacterial products from the dialy-
sate [9, 10]. Hence, cytokine production by peripheral blood
mononuclear cells (PBMC), which is an extremely sensitive
marker of the presence of endotoxin, has been used to demon-
strate the transmembrane passage of bacterial products from the
dialysate to the blood compartment [9—13]. These studies used
the production of interleukin-1 (IL-i) and/or tumor necrosis
factor (TNF) by PBMC as markers of endotoxin transfer across
dialysis membranes during in vitro hemodialysis [9—12]. However,
in the majority of these studies, normal saline, tissue culture
medium or 10% plasma rather than whole blood was circulated in
the blood compartment [9—11]. Further, in these in vitro models
the presence or absence of backfiltration was estimated and not
measured [11].
In order to more closely mimic clinical hemodialysis, we used a
model in which whole blood was circulated in the blood compart-
ment, and dialysate contaminated with Pseudomonas maltophilia
(a common water bacteria) was circulated in the dialysate com-
partment. To study the diffusive and convective transfer of
bacterial products, we developed a computerized in vitro dialysis
model which provides continuous pressure recording from arte-
rial, venous, dialysate inflow and outflow ports. By virtue of a
computer controlled on-line infusion pump, this model permits
control of ultrafiltration/backflltration. This model was used to
study the diffusive and convective transfer of cytokine-inducing
substances from dialysate to blood compartment in select high-
flux (polyamide) and low-flux (hemophan) membranes. The pro-
duction of IL-I f3 and IL-i receptor antagonist (IL-iRa) by PBMC
in the blood compartment was used as an index of the passage of
bacterial products from the dialysate.
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Fig. 1. Computerized in vitro hemodialysis
model.
Study design
This study was designed to investigate the transmembrane
passage of bacterial products from the dialysate to the blood
compartment during in vitro dialysis. Bicarbonate dialysate con-
taminated with Pseudomonas maltophilia was circulated in the
dialysate compartment, and cytokine production in the blood
compartment was used as the indicator of transmembrane passage
of bacterial products. This study sought to evaluate the following:
(1) to compare the permeability of high-flux synthetic membranes
(polyamide) with low-flux cellulose membranes (hemophan).
Both polyamide and hemophan membranes have a low comple-
ment-activating potential, and were selected to eliminate comple-
ment activation as a variable in this study design; (2) to examine
the roles of convective and diffusive transport in the transmem-
brane passage of bacterial products. The reverse transfer of
bacterial products from the dialysate to blood during mandatory
ultrafiltration represented diffusive transport, and the transfer
during backfiltration represented convective transport; and (3) to
determine whether IL-iRa is a more sensitive indicator than
IL-i /3 in detecting the transmembrane passage of bacterial prod-
ucts from the dialysate.
Computerized in vitro hemodialysis model
We have developed a computerized in vitro dialysis model in
collaboration with Sven Jonsson (Gambro AB, Lund, Sweden)
(Fig. 1) which provides continuous measurement of pressures at
the arterial (A), venous (B), dialysate inflow (C) and dialysate
outflow (D) ports of the in vitro circuit (Figs. 2 and 3, upper
panels). These measurements are integrated by a computer which
then computes continuous "two-point" pressure measurements
(difference between venous pressure and dialysate inflow pres-
sure; Figs. 2 and 3, middle panels). Further, a computer controlled
on-line infusion pump enables upward or downward adjustment
of the "two-point" pressure by adjusting the infusion rate and thus
the pressure in the arterial limb. Positive or negative "two-point"
pressures result in ultrafiltration and backfiltration, respectively.
For the purposes of this study, a +10 mm "two-point" pressure
was used to ensure ultrafiltration in the strict absence of backfil-
tration, and a —10 mm "two-point" pressure was used to ensure
consistent backfiltration (Figs. 2 and 3, lower panels).
Ps maltophilia-contaminated dialysate
Ps maltophilia-contaminated dialysate was a gift from Dr. An
Mahiout and Professor Karl M. Koch (Department of Nephrol-
ogy, Medizinische Hochschule, Hannover, Germany). Briefly, Ps
maltophilia was cultured in standard bicarbonate dialysate. During
the early stage of the growing phase (10 to 10), the contami-
nated dialysate was filtered through a 300 kDa membrane and the
filtrate lyophilized. The lyophilized contaminated dialysate was
reconstituted immediately prior to the in vitro experiment. The
reconstituted dialysate induced 5914 928 pg of IL-lRaI2.5
million PBMC and 8728 835 pg of IL-1f312.5 million PBMC.
In vitro hemodialysis with contaminated dialysate
Heparinized (10 U/mI) whole blood (150 ml) was circulated
through the blood compartment for 120 minutes at 100 ml/min.
Bicarbonate dialysate contaminated with Ps maltophilia filtrate
was circulated through the dialysate compartment at 100 mi/mm.
A "two-point" pressure of + 10 mm of Hg (ultrafiltration) was
maintained for the first 60 minutes and —10 mm of Hg (backfil-
tration) for the next 60 minutes. Whole blood samples (10 ml)
were drawn from the blood at 0, 60 and 120 minutes. PBMC
harvested from these samples were incubated for 24 hours in
tissue culture medium and total cell-associated IL-iRa and IL-1/3
measured. In addition, 0.5 ml samples of dialysate were collected
at 0, 60 and 120 minutes. PBMC from the same donor were
incubated directly for 24 hours with the contaminated dialysate
drawn at the three time points. After 24 hour incubation, total
cell-associated IL-iRa and IL-1/3 were measured. Paired experi-
ments were performed with eight donors.
In vitro production of IL-i and IL-iRa by peripheral blood
mononuclear cells
Water and tissue culture media used in this study were sub-
jected to ultrafiltration using a polyamide hollow-fibre ultrafilter
Methods
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(U2000, Gambro AB, Hechingen, Germany) to remove cytokine-
inducing agents [14]. Peripheral blood mononuclear cells (PBMC)
were harvested as previously described [15]. Briefly, each 10 ml
sample of blood was diluted with 10 ml of sterile pyrogen-free
normal saline (Abbott Laboratories, Rockford, IL, USA) and
underlayered with 10 ml of Ficoll-Hypaque. The tube was centri-
fuged at 450 g for 45 minutes at room temperature. The PBMC
layer was harvested, washed in saline and centrifuged at 400 g for
10 minutes. The cells were washed in saline two additional times.
The cells were then resuspended in ultrafiltered tissue culture
medium (RPMI 1640, pH 7.4; Sigma Chemical Co., St. Louis,
MO, USA), containing 10 mmollliter L-glutamine, 24 mmollliter
NaHCO3 (Mallinckrodt, Paris, KY, USA), 10 mmol/liter HEPES
(Sigma), 100 U/ml penicillin and 100 sg/ml streptomycin (Irvine
Scientific, Santa Ana, CA, USA). Peripheral blood mononuclear
cells were counted using a standard hemocytometer and a sus-
pension of 5 X 106 PBMC/ml prepared in RPMI. A 0.5 ml
suspension of PBMC harvested from the blood compartment at
each time point was aliquoted into 12 X 75 mm polypropylene
tubes to which 0.5 ml of RPMI was added. In addition, to 0.5 ml
suspensions of PBMC from the same donor, 0.5 ml aliquots of
contaminated dialysate drawn at different time points was added.
All tubes were incubated upright at 37°C with CO2. At the end of
24 hours, the tubes were frozen at —70°C. The cell suspensions
were then subjected to two additional freeze-thaw cycles. Undi-
luted or diluted samples were added to radioimmunoassay (RIA)
buffer (0.01 mol/liter phosphate-buffered saline, pH 7.4, 0.25%
bovine serum albumin and 0.05% sodium azide) and total IL-iRa
and IL-1f3 synthesis (cell-associated and secreted) were measured
by specific non-cross-reactive RIA [15, 16]. The IL-113 or IL-iRa
concentrations were then read from a logit plot of percent specific
binding versus the log concentration of a serially diluted IL-lp or
IL-iRa from the linear portion of the curve (usually between 35%
and 85% specific binding). The limits of detection of the RIA for
IL-1f3 and IL-iRa were 20 pg/ml and 80 pg/ml, respectively.
Statistics
Statistical analysis was performed using the SYSTAT software
package (SYSTAT Inc., Evanston, IL, USA). Univariate and
multivariate repeated measures analysis were employed to test the
significance of differences. Data are expressed as mean stan-
dard error of the mean (sEM). Cytokine production by PBMC are
expressed as pgI2.5 million PBMC. Differences were considered
significant at <0.05.
Results
Pressure-volume measurements
The initial volume in the blood compartment was 150 ml in both
arms of the study. Due to the high ultrafiltration coefficient of
polyamide membranes, the arterial limb pressures were lower (20
to 40 mm) than hemophan membranes (40 to 60 mm; Figs. 2 and
3, upper panels). The ultrafiltration volumes during the first hour
(+ 10 mm "two-point" pressure) were 963 29 ml for polyamide
and 96 4 ml for hemophan. Consequently, the infusion volume
required to maintain a + 10 mm "two-point" pressure was 1132
34 mI/hr for polyamide compared to 175 8 ml/hr for hemophan.
In contrast, during the second hour (—10 mm "two-point" pres-
sure) the ultrafiltration volumes were 57 22 ml and 34 8 ml,
respectively, with polyamide and hemophan membranes.
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Fig. 2. Continuous pressure recordings during in vitro dialysis with poly-
amide membranes. The upper panel shows the arterial (A), venous (B),
dialysate inflow (C) and dialysate outflow (D) pressures. The middle panel
shows the venous (B) and dialysate inflow (C) pressures. The lower panel
shows the net "two-point" pressure (venous pressure-dialysate inflow
pressure). During the first hour, a + 10 mm "two-point" pressure was used
to ensure ultrafiltration in the strict absence of backfiltration, and during
the second hour, a 10 mm "two-point" pressure was used to ensure
consistent backfiltration.
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Fig. 3. Continuous pressure recordings during in vitro dialysis with he-
mophan membranes. The upper panel shows the arterial (A), venous (B),
dialysate inflow (C) and dialysate outflow (D) pressures. The middle panel
shows the venous (B) and dialysate inflow (C) pressures. The lower panel
shows the net "two-point" pressure (venous pressure-dialysate inflow
pressure). During the first hour, a + 10 mm "two-point" pressure was used
to ensure ultrafiltration in the strict absence of backfiltration, and during
the second hour, a —10 mm "two-point" pressure was used to ensure
consistent backfiltration.
Production of IL-iRa and IL -1 f3 by PBMC from the blood
compartment incubated for 24 hours in tissue culture medium
During in vitro dialysis with polyamide membranes, the produc-
tion of IL-iRa by PBMC harvested from the blood compartment
at 0, 60 and 120 minutes was 515 118,785 209and 702 123,
respectively (Fig. 4A). At the same three time points, the produc-
tion of IL-iRa by PBMC from the blood compartment of
hemophan membranes was 1175 365, 3865 1847 and 2284
886, respectively. The production of IL-iRa by PBMC from the
blood compartment of polyamide membranes was significantly
lower than that observed with hemophan (P = 0.01), suggesting
that polyamide membranes permit a lower transmembrane pas-
sage of cytokine-inducing substances from the dialysate to blood
compartment compared to hemophan membranes.
In contrast to IL-iRa, the production of IL-113 by PBMC
harvested from the blood compartment with both membranes was
uniformly low (Fig. 4B). The production of IL-1f3 by PBMC
harvested from the blood compartment from polyamide mem-
branes at 0, 60 and 120 minutes was 58 27, 34 8 and 58 14,
respectively. At the same three time points, the production of
IL-iRa by PBMC from the blood compartment of hemophan
membranes was 43 7, 108 49 and 39 8, respectively (F>
0.05). These data suggest that IL-1/3 is a less sensitive indicator
than IL-iRa of the transmembrane passage of cytokine-inducing
substances from the dialysate to blood compartment.
Production of IL-iRa by PBMC from healthy volunteers incubated
for 24 hours with contaminated dialysate
The production of IL-iRa by PBMC incubated with dialysate
drawn from the dialysate circuit of polyamide membranes at 0, 60
and 120 minutes was 4721 347, 5035 1280 and 4466 561,
respectively (Fig. 5). At the same three time points, the produc-
tion of IL-iRa by PBMC incubated with dialysate drawn from the
dialysate circuit of hemophan membranes was 7108 1722, 11296
4585 and 7616 1822, respectively. The production of IL-iRa
by PBMC incubated with dialysate from the dialysate circuit of
polyamide membranes was lower than that observed with he-
mophan (P = 0.05).
Ultrafiltration volumes and their impact on transfer of Ps
maltophilia toxins across polyamide and hemophan membranes
During in vitro dialysis, the initial volume of contaminated
dialysate was 566 9 ml and 461 11 ml, respectively, with
polyamide and hemophan (Fig. 6). However, after in vitro dialysis,
the dialysate volume with polyamide membranes was 1530 31
and 1587 46, respectively, at 60 and 120 minutes. In contrast,
the dialysate volume with hemophan membranes was 557 13
and 590 19, respectively, at 60 and 120 minutes (P < 0.001).
Further, the production of IL-iRa by PBMC from the blood
compartment demonstrated a direct correlation (r = 0.307) with
the production of IL-iRa by PBMC incubated with the contam-
inated dialysate. This correlation however did not reach statistical
significance (P = 0.08). These data suggest that one of the causes
for the lower production of IL-iRa by PBMC from the blood
compartment of polyamide 'iiembranes could be the greater
dilution of the dialysate contaminants by the high ultrafiltration
rates encountered with polyamide membranes.
To adjust for dilution of the contaminants by ultrafiltration, we
expressed the transfer of cytokine-inducing substances across the
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Fig. 5. Production of IL-IRa by PBMC from healthy volunteers incubated
for 24 hours with contaminated dialysate. The production of IL-iRa by
PBMC incubated with dialysate drawn from the dialysate circuit of
polyamide membranes at 0, 60 and 120 minutes was lower than that
observed with hemophan (P 0.05).
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Fig. 4. Production of IL-iRa and IL-ip by PBMC from the blood compart-
rnent incubated for 24 hour in tissue culture medium (RPM!). At 0, 60 and
120 minutes, the production of IL-iRa by PBMC from the blood
compartment of polyamide membranes was significantly lower than that
observed with hemophan (P = 0.01) (A). The production of IL-13 by
PBMC harvested from the blood compartments from both membranes
was uniformly low (B), and was not significantly different between mem-
branes.
membrane as a ratio of the production of IL-iRa by PBMC from
the blood compartment to the production of IL-iRa by PBMC
incubated with the contaminated dialysate (Fig. 7). This relative
transfer of cytokine-inducing substances was 0.10 0.02, 0.20
0.05 and 0.16 0.03, respectively at 0, 60 and 120 minutes for
polyamide membranes. At the same time points, the relative
transfer of cytokine-inducing substances was 0.17 0.04, 0.54
0.21 and 0.29 0.09, respectively, for hemophan membranes,
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Fig. 6. Ultrafiltration volumes. The ultrafiltration volumes and conse-
quently the dialysate volumes with polyamide membranes at 60 and 120
minutes were significantly higher than those with hemophan membranes
(P < 0.001).
which was significantly higher (P 0.03) than that with polyamide
membranes.
Diffusive versus convective passage of IL-iRa inducing substances
from the dialysate to blood
During the ultrafiltration phase of the experiment (first hour),
the production of IL-iRa by PBMC from the blood compartment
rose from 515 118 to 785 209 with polyamide membranes,
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Fig. 7. Ratio of the production of IL-IRa by PBMC from the blood
compartment to the production of IL-iRa by PBMC incubated with the
contaminated dialysate (transfer of cytokine-inducing substances across the
dialysis membrane). The transfer of cytokine-inducing substances across
the dialysis membrane at 0, 60 and 120 minutes across polyamide
membranes was significantly lower (P = 0.03) than that across hemophan
membranes.
and from 1175 365 to 3865 1847 with hemophan membranes,
suggesting diffusive transport of bacterial products across the
membrane (Fig. 4A). In contrast, at the end of the backfiltration
phase (second hour), there was no further rise in the production
of IL-iRa by PBMC from the blood compartment (702 123 with
polyamide, and 2284 886 with hemophan).
Discussion
Dialysis with high-flux as well as high efficiency membranes is
associated with an increased risk for backflltration [8]. This has
raised concerns that patients dialyzed with these membranes may
be at a high risk of being exposed to bacterial contaminants in the
dialysate [3]. Further, reprocessing of dialyzers has been shown to
increase the permeability of high-flux membranes [17, 18]. This
could potentially accentuate the risk of transmembrane transfer of
bacterial products from the dialysate to the blood compartment.
Indeed, the Center for Disease Control and Prevention (USA)
has reported a significant correlation between pyrogen reactions
during dialysis and the use of high-flux as well as reprocessed
dialyzers [2]. However, the results of this study allay the majority
of these fears concerning high-flux dialysis. We observed that
high-flux synthetic membranes such as polyamide are less likely to
permit the transfer of bacterial products from the dialysate than
low-flux cellulosic membrane such as hemophan. We also ob-
served that transmembrane passage of bacterial products occurs
despite the absence of backfiltration, suggesting an important role
for diffusive transfer of these toxins across dialysis membranes.
The results of this study validate the observations of previous
investigators that non-cellulosic high-flux membranes are less
likely to permit the transmembrane passage of bacterial toxins
compared to cellulosic membranes [11]. However, in this study,
part of the protection provided by polyamide membranes was due
to the higher ultrafiltration rates and consequent dilution of
bacterial toxins in the dialysate. Nonetheless, when adjusted for
the effect of dilution, the transfer of bacterial products across
polyamide membranes was less than half of that observed with
hemophan membranes. These data support the concept that
adsorption of bacterial toxins on the dialysate side of synthetic
membranes may prevent the transfer into the blood compartment
[14]. Indeed, others have shown that synthetic membranes such as
polysulfone and polyacrylonitrile bind significantly higher
amounts of I'25-labeled lipopolysaccharide than cuprophan mem-
branes [13]. It is postulated that the interactions between hydro-
phobic domains on the polyamide membrane and hydrophobic
domains on the bacterial toxins lead to avid adsorption of these
toxins on the dialysate side of the membrane, and prevent the
transfer into the blood compartment [141. Given the fact that
synthetic high-flux membranes such as polyamide are less likely to
permit the transmembrane passage of bacterial toxins compared
to cellulosic membranes, the cause of the increased frequency of
pyrogen reactions in patients dialyzed with high-flux membranes
remains unexplained.
The reverse transfer of solutes from the dialysate to blood
compartment (back clearance) is the sum total of the convective
(backfiltration) and diffusive transport (backdiffusion). The risk of
backfiltration is dependent on membrane characteristics, blood
and dialysate flow rates, ultrafiltration rates and dialysate flow
patterns [8, 19, 20]. This risk is maximum with high-flux followed
by high-efficiency and low-flux membranes [8]. Backfiltration rates
are less with cocurrent dialysate flows as opposed to the usual
countercurrent flow. Backfiltration is inversely related to ultrafil-
tration rates, and although it tends to decline at high ultrafiltra-
tion rates, may not be totally abolished [8]. Indeed, we observed
that to prevent backfiltration, polyamide membranes required
ultrafiltration rates of about 1000 ml/hr compared to only 100
ml/hr for hemophan membranes, suggesting that the risk of
backfiltration is ever present during high-flux dialysis. Even if
backfiltration were eliminated, transfer of solutes from the dialy-
sate to blood compartment by backdiffusion of solutes continues
to occur [19]. Therefore, it is important to determine the roles of
convection and diffusion in the transfer of bacterial products from
the dialysate to blood.
Previous efforts at determining the role of backfiltration in the
transfer of bacterial products across membranes have employed in
vitro hemodialysis models in which blood and dialysate volumes
were fixed, and pressures were not measured [10, 11]. In these
models, the risk and volume of backfiltration could at best be
estimated and not measured. The in vitro dialysis model used in
this study is a significant improvement over previous models, and
provided continuous arterial, venous, dialysate inflow, dialysate
outflow as well as "two-point" pressure measurements throughout
the course of the experiment. In comparison to hemophan
membranes, dialysis with polyamide membranes was associated
with higher ultrafiltration rates and lower pressures in the arterial
limb. Ultrafiltration volumes were, however, replaced by the
computer-driven infusion pump so that venous pressures were
maintained at 10 mm of Hg above the dialysate inflow pressures,
to prevent backfiltration.
An increase in cytokine production by PBMC from the blood
compartment was observed within the first hour of dialysis with
both membranes. This increase occurred in the strict absence of
backfiltration, suggesting diffusive transfer of bacterial products
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across dialysis membranes. Therefore, any condition that in-
creases diffusive transport such as dialyzers with large surface
areas as well as high blood and dialysate flow rates could increase
the reverse transfer of bacterial products from the dialysate. This
risk is not greater for synthetic high-flux membranes such as
polyamide. In fact, we and others have demonstrated that this risk
is lower for polyamide membranes compared to traditional cellu-
losic membranes [11].
Interestingly, during the second hour of dialysis (backfiltration),
no further increase in cytokine production was observed. At first
glance, this may suggest that convective transfer does not play a
role in the transmembrane passage of bacterial products. How-
ever, the failure to observe a further increase in cytokine produc-
tion during the backflltration phase of the experiment could be
due to the tolerance induced by exposure to bacterial products
during the first hour. Indeed, Mege and colleagues have observed
an increase in plasma endotoxin levels during the course of
clinical dialysis with PAN membranes and a concurrent down-
regulation of CD14 antigen expression on monocytes [21]. Fur-
ther, Granowitz and colleagues have shown that a second expo-
sure to endotoxin in human volunteers previously injected with
endotoxin results in significantly lower levels of cytokine produc-
tion compared to controls who were administered saline [221.
Therefore, the results of this study do not exclude an important
role for backfiltration in the reverse transfer of bacterial products
from the dialysate.
In the past, the transmembrane passage of cytokine-inducing
substances has been studied using in vitro models in which normal
saline, tissue culture medium or 10% plasma rather than whole
blood was circulated in the blood compartment [9—11]. However,
the recent characterization of lipopolysaccharide binding protein
(LBP), soluble CD14 receptors and bactericidal/permeability in-
creasing factor (BPI) [23—28] question the clinical relevance of
these models. Lipopolysaccharide binding protein is synthesized
by the liver and binds to the lipid A fraction of LPS [23—25]. The
LBP-LPS complex binds to the CD14 receptor on monocytes and
enhances the production of IL-i and TNF (25). Hence, the
absence of LBP in in vitro models using normal saline or tissue
culture media may lead to an underestimation of the effect of
cytokine-inducing bacterial products that cross the dialysis mem-
branes. Bactericidal/permeability increasing factor is a neutrophil
granule protein which binds to LPS and "neutralizes" its biolog-
ical effects [26—28]. Indeed, BPI is released during dialysis with
both cellulosic and synthetic membranes [29]. The absence/low
levels of BPI in in vitro models using 10% plasma may overesti-
mate the effect of cytokine-inducing bacterial substances that
cross the dialysis membranes. Therefore, the whole blood model
that we used in this study is a closer representation of the
conditions present during clinical hemodialysis.
Previous studies have used IL-1f3 or TNFa production by
PBMC from the blood compartment to demonstrate the passage
of bacterial products from the dialysate [9—12]. This study dem-
onstrates that the production of interleukin-1 receptor antagonist
by PBMC is a more sensitive indicator of the transmembrane
passage of bacterial toxins than interleukin-1 13. This is in keeping
with our previous observations that IL-iRa is a more sensitive
indicator of dialysis-induced cytokine production than IL-113 [30,
31]. Alternatively, this response may be specific to the Ps malto-
philia filtrate used in this study. Indeed, Evans and Holmes have
demonstrated that cytokine production by PBMC in the blood
compartment varies with the type and concentration of the
contaminating organism in the dialysate [10]. While dialysate
contaminated with Escherichia coli and Pseudomonas aeruginosa
induced IL-1f3 and TNFa production in the blood compartment,
this phenomenon was not observed with dialysate contaminated
with Enterobacter cloacae [10]. Therefore, whether IL-iRa is a
more sensitive indicator of the transmembrane passage of toxins
from other bacterial contaminants needs to be confirmed.
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